Publications by authors named "Jan Linder"

Claim this Profile
N
NfL as a biomarker for neurodegeneration and survival in Parkinson disease.
David Bäckström, Jan Linder, Susanna Jakobson Mo, Katrine Riklund, Henrik Zetterberg

Neurology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study.
Andreas Puschmann, Itzia Jiménez-Ferrer, Elin Lundblad-Andersson, Emma Mårtensson, Oskar Hansson, Jan Linder

Parkinsonism Relat Disord· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voice Tremor Outcomes of Subthalamic Nucleus and Zona Incerta Deep Brain Stimulation in Patients With Parkinson Disease.
Fredrik Karlsson, Elin Malinova, Katarina Olofsson, Patric Blomstedt, Jan Linder

J Voice· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
David Bäckström, Gabriel Granåsen, Magdalena Eriksson Domellöf, Jan Linder, Susanna Jakobson Mo

Neurology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine transporter imaging with [F]FE-PE2I PET and [I]FP-CIT SPECT-a clinical comparison.
Susanna Jakobson Mo, Jan Axelsson, Lars Jonasson, Anne Larsson, Mattias J Ögren, Jan Linder

EJNMMI Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.
Kristin Aaser Lunde, Janete Chung, Ingvild Dalen, Kenn Freddy Pedersen, Jan Linder

Alzheimers Dement· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand F-FE-PE2I in Human Subjects.
Helena Lizana, Lennart Johansson, Jan Axelsson, Anne Larsson, Mattias Ögren, Jan Linder

J Nucl Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation.
Patric Blomstedt, Rasmus Stenmark Persson, Gun-Marie Hariz, Jan Linder, Anna Fredricks

J Neurol Neurosurg Psychiatry· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study.
David Bäckström, Magdalena Eriksson Domellöf, Gabriel Granåsen, Jan Linder, Sofia Mayans

J Neurol Sci· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
Victoria Berge-Seidl, Lasse Pihlstrøm, Jodi Maple-Grødem, Lars Forsgren, Jan Linder

Neurosci Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swallowing safety in Parkinson's disease after zona incerta deep brain stimulation.
Stina Sundstedt, Lina Holmén, Elin Rova, Jan Linder, Erik Nordh

Brain Behav· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Oskar Hansson, Shorena Janelidze, Sara Hall, Nadia Magdalinou, Andrew J Lees, Jan Linder

Neurology· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neck Muscle Strain in Air Force Pilots Wearing Night Vision Goggles.
Magnus Wallquist Pousette, Riccardo Lo Martire, Jan Linder, Mats Kristoffersson, Björn O Äng

Aerosp Med Hum Perform· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swallowing Quality of Life After Zona Incerta Deep Brain Stimulation.
Stina Sundstedt, Erik Nordh, Jan Linder, Johanna Hedström, Caterina Finizia

Ann Otol Rhinol Laryngol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare variants in dementia genes and Parkinson's disease.
Zafar Iqbal, Lasse Pihlstrøm, Aina Rengmark, Sandra Pilar Henriksen, Jan Linder

Eur J Hum Genet· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low frequency of GCH1 and TH mutations in Parkinson's disease.
Aina Rengmark, Lasse Pihlstrøm, Jan Linder, Lars Forsgren, Mathias Toft

Parkinsonism Relat Disord· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.
Sven E Pålhagen, Olof Sydow, Anders Johansson, Dag Nyholm, Bjorn Holmberg, Jan Linder

Parkinsonism Relat Disord· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term dopamine transporter imaging in Parkinson's disease treated with zona incerta stimulation.
Susanna Jakobson Mo, Jan Linder, Patric Blomstedt, Gabriel Granåsen, Lars Forsgren

Nucl Med Commun· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laterality and deep brain stimulation of the subthalamic nucleus: applying a dichotic listening task to patients treated for Parkinson's disease.
Rickard L Sjöberg, Björn Häggström, Johanna Philipsson, Jan Linder, Marwan Hariz

Neurocase· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Christina M Lill, Aina Rengmark, Lasse Pihlstrøm, Isabella Fogh, Aleksey Shatunov, Jan Linder

Alzheimers Dement· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease.
Mevludin Memedi, Dag Nyholm, Anders Johansson, Sven Pålhagen, Thomas Willows, Jan Linder

IEEE J Biomed Health Inform· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.
Sofie Degerman, Magdalena Domellöf, Mattias Landfors, Jan Linder, Mathias Lundin

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.
David C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, Bob Olsson, Annika Öhrfelt

JAMA Neurol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.
Lasse Pihlstrøm, Aina Rengmark, Kari Anne Bjørnarå, Nil Dizdar, Camilla Fardell, Jan Linder

J Hum Genet· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Visual Assessment of Dopamine Transporter Imaging in Early Parkinsonism.
Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Katrine Riklund

Mov Disord Clin Pract· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis